UBS O'Connor’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $440K | Sell |
127,036
-255,864
| -67% | -$885K | 0.02% | 251 |
|
|
2025
Q1 | $1M | Buy |
382,900
+52,201
| +16% | +$137K | 0.03% | 176 |
|
|
2024
Q4 | $1.36M | Buy |
330,699
+218,651
| +195% | +$901K | 0.04% | 200 |
|
|
2024
Q3 | $793K | Buy |
+112,048
| New | +$793K | 0.02% | 296 |
|
|
2024
Q2 | – | Sell |
-100,039
| Closed | -$830K | – | 538 |
|
|
2024
Q1 | $830K | Sell |
100,039
-33,694
| -25% | -$280K | 0.02% | 290 |
|
|
2023
Q4 | $1.47M | Sell |
133,733
-13,113
| -9% | -$144K | 0.05% | 218 |
|
|
2023
Q3 | $1.23M | Buy |
146,846
+50,461
| +52% | +$424K | 0.02% | 302 |
|
|
2023
Q2 | $1.21M | Buy |
96,385
+52,285
| +119% | +$657K | 0.03% | 361 |
|
|
2023
Q1 | $726K | Buy |
+44,100
| New | +$726K | 0.02% | 426 |
|